Dr. Ian Rabinowitz
Claim this profileUniversity of New Mexico Cancer Center
Studies Melanoma
Studies Cutaneous Melanoma
7 reported clinical trials
16 drugs studied
Area of expertise
1Melanoma
Stage IV
BRAF positive
Stage III
2Cutaneous Melanoma
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Ian Rabinowitz is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Ian Rabinowitz
Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ian Rabinowitz has experience with
- Ipilimumab
- Nivolumab
- Biospecimen Collection
- Crizotinib
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
Breakdown of trials Ian Rabinowitz has run
Melanoma
Cutaneous Melanoma
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ian Rabinowitz specialize in?
Ian Rabinowitz focuses on Melanoma and Cutaneous Melanoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Ian Rabinowitz currently recruiting for clinical trials?
Yes, Ian Rabinowitz is currently recruiting for 4 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Ian Rabinowitz has studied deeply?
Yes, Ian Rabinowitz has studied treatments such as Ipilimumab, Nivolumab, Biospecimen Collection.
What is the best way to schedule an appointment with Ian Rabinowitz?
Apply for one of the trials that Ian Rabinowitz is conducting.
What is the office address of Ian Rabinowitz?
The office of Ian Rabinowitz is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.